During the past decade, Tangdu Hospital conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 4 clinical trials were completed, i.e. on average, 5.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 1 clinical trials were completed. i.e. 3.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tangdu Hospital" #1 sponsor was "Tang-Du Hospital" with 26 trials, followed by "Nanfang Hospital of Southern Medical University" with 6 trials sponsored, "Xijing Hospital" with 5 trials sponsored, "Peking University Third Hospital" with 4 trials sponsored and "Chongqing Jiachen Biotechnology Ltd." with 4 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tangdu Hospital" #1 collaborator was "Tang-Du Hospital" with 14 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 8 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 6 trials as a collaborator, "Changhai Hospital" with 5 trials as a collaborator and "China Meitan General Hospital" with 5 trials as a collaborator. Other collaborators include 355 different institutions and companies that were collaborators in the rest 214 trials.

According to Clinical.Site data, the most researched conditions in "Tangdu Hospital" are "Hepatitis B, Chronic" (6 trials), "Non-small Cell Lung Cancer" (6 trials), "Chronic Hepatitis B" (5 trials), "Fertilization" (4 trials) and "Acute Stroke" (2 trials). Many other conditions were trialed in "Tangdu Hospital" in a lesser frequency.

Most popular intervention types in "Tangdu Hospital" are "Drug" (46 trials), "Procedure" (18 trials), "Device" (13 trials), "Other" (12 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Surgeries" (7 trials), "Sevoflurane" (4 trials), "Propofol" (3 trials) and "DAG181" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tangdu Hospital" are 86 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Tangdu Hospital". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Tangdu Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Tangdu Hospital, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 27 trials that are defined as “Not Applicable".